Skip to content

Journal · Cancer epidemiology · Updated 21 November 2026

Cancer Causes & Control

Read Cancer Causes & Control articles on DeepDyve. No university library needed.

Cancer Causes & Control has published since 1990 and covers the causes, prevention and control of cancer in human populations, from delays in breast cancer surgery and racial disparities to beliefs about alcohol and cancer survival after the COVID-19 pandemic. Springer Nature publishes it. A DeepDyve subscription lets you read it in full, alongside millions of articles from other journals licensed from publishers including Springer Nature.

Then $59 a month or $499 a year. A credit card is required; cancel during the trial and you won’t be charged. You read articles online; PDFs are sold separately.

Personal plans aren’t for business use. Reading for work? See Enterprise.

Cover of Cancer Causes & Control
Journal cover

Cancer Causes & Control at a glance

Full title
Cancer Causes & Control
Abbreviation (NLM)
Cancer Causes Control
Publisher
Springer Nature
Print ISSN
0957-5243
Online ISSN (eISSN)
1573-7225
First published
1990
Subjects
Epidemiology, Neoplasms
Access model
Hybrid (52% free to read in 2026)

Ways to access Cancer Causes & Control

52% of the articles Cancer Causes & Control published from January 1 to November 20, 2026 are open access and free to read. For the rest, look for the authors’ manuscript, check a library, or read them on DeepDyve.

  1. Open access articles. 52% of Cancer Causes & Control articles published from January 1 to November 20, 2026 carry a Creative Commons license, per Crossref, and are free to read. They’re marked “Open access” below.
  2. The authors’ accepted manuscript. For subscription articles, Springer Nature lets authors post their accepted manuscript on their own website as soon as it’s accepted, and in a repository such as PubMed Central 12 months after publication.
  3. Ask the authors. Authors can also share a free, read-only link to their published article through Springer Nature’s SharedIt, so it’s worth asking the authors directly.
  4. NIH-funded research. For papers accepted on or after July 1, 2025, the US National Institutes of Health requires the accepted manuscript in PubMed Central, free with no embargo from the official publication date.
  5. A library. Your university, hospital or public library may subscribe to Cancer Causes & Control. Check its journal list and whether it offers remote access.
  6. DeepDyve. Read Cancer Causes & Control articles online for $59 a month or $499 a year after a free first month. Articles marked LitStream below are in DeepDyve’s LitStream collection, which a subscription lets you read online. PDFs are sold separately, and availability varies by article.

Sources: Springer Nature self-archiving policy; NIH Public Access Policy; open access share from Crossref license data.

Impact factor and metrics

Cancer Causes & Control’s 2025 Journal Impact Factor is 2.2, and its 5-year Impact Factor is 2.5.

2.2

Journal Impact Factor (2025)

2.5

5-year Impact Factor (2025)

6 days

Median time to first decision

Source: journal metrics on the Cancer Causes & Control homepage (Springer Nature), checked November 21, 2026. Impact Factor from Clarivate Journal Citation Reports.

Recent Cancer Causes & Control research worth reading

Published January to February 2026. Summaries describe what the authors report.

  1. Open accessBreast cancer · Health disparities

    Delay in breast cancer surgery: evaluating patient, healthcare access, and social vulnerability predictors

    Among 6,279 Arkansas women with breast cancer, the authors report that 12% had surgery more than 60 days after diagnosis, with higher odds of delay for non-Hispanic Black patients (aOR 1.82) and for residents of counties with high housing/transportation vulnerability.

    Boyd et al. · Cancer Causes & Control, published online February 10, 2026 · DOI 10.1007/s10552-026-02127-2

  2. Open accessBreast cancer · Selenoproteins

    Contributions of selenoproteins to breast cancer etiology and racial disparity

    The authors report elevated SELENOF and eIF4a3 in breast cancer tissues, higher still in tissues from African American women, who also showed a more frequent SELENOP polymorphism, suggesting these proteins may contribute to racial disparities in outcomes.

    Bera et al. · Cancer Causes & Control, published online January 21, 2026 · DOI 10.1007/s10552-025-02123-y

  3. LitStreamAlcohol · Cancer awareness

    Opinions on the effect of alcohol on cancer risk among US adults in 2024

    Analyzing 5,466 respondents to the 2024 Health Information National Trends Survey, the authors report that 39.4% of US adults said alcohol increases cancer risk, 50.4% did not know and 10.2% said it decreases risk or has no effect.

    Singh et al. · Cancer Causes & Control, published online January 17, 2026 · DOI 10.1007/s10552-025-02084-2

  4. LitStreamCancer survival · COVID-19

    Monitoring cancer survival in Belgium: early insights 3 years after the COVID-19 pandemic

    Using Belgian registry data for tumours diagnosed from 2017 to 2021, the authors report that 1- and 2-year relative survival dipped for 2020 diagnoses, while 3-year survival (72.0%) matched 2019 (72.2%) and 2021 estimates followed pre-pandemic trends.

    Tambuyzer et al. · Cancer Causes & Control, published online January 21, 2026 · DOI 10.1007/s10552-025-02121-0

  5. LitStreamCervical cancer · Risk factors

    Age at first marriage, menopause status and cervical cancer risk in a middle eastern country: a national cancer registry-based case–control study

    In a case–control study of 50 cases and 155 controls in Kuwait, the authors report that first marriage before age 25, being in menopause and unawareness of HPV vaccine availability were independently associated with cervical cancer, calling the findings preliminary.

    Al-Mutairi et al. · Cancer Causes & Control, published online January 17, 2026 · DOI 10.1007/s10552-025-02087-z

See every Cancer Causes & Control article on DeepDyve

Questions about Cancer Causes & Control

How can I read Cancer Causes & Control articles without a subscription?

52% of Cancer Causes & Control articles published from January 1 to November 20, 2026 are open access and free to read. For subscription articles, Springer Nature lets authors post their accepted manuscript on their own website as soon as it’s accepted, and in a repository such as PubMed Central 12 months after publication. Your library may also subscribe. DeepDyve lets you read Cancer Causes & Control articles online for $59 a month or $499 a year after a free first month.

What is the abbreviation for Cancer Causes & Control?

Cancer Causes & Control’s NLM (PubMed) abbreviation is Cancer Causes Control.

What is the ISSN of Cancer Causes & Control?

The print ISSN is 0957-5243 and the online ISSN is 1573-7225.

What is the impact factor of Cancer Causes & Control?

Cancer Causes & Control’s Journal Impact Factor is 2.2 (2025), and its 5-year Impact Factor is 2.5, according to Springer Nature’s published metrics.

Is Cancer Causes & Control open access?

Cancer Causes & Control is a hybrid journal: authors can choose to publish open access or under the subscription model. From January 1 to November 20, 2026, 94 of 180 Cancer Causes & Control articles (52%) carry a Creative Commons license, per Crossref.

Cancer Causes & Control articles on DeepDyve are licensed from Springer Nature. Journal facts as of 21 November 2026.

Start reading Cancer Causes & Control today

One month free, then less than $2 a day. Cancer Causes & Control, plus millions of articles from thousands of journals.

Start free month

Like this: